سعر فيكسول Vexol‏ 1% قطرة عين 5 مل 2026

Rimexolone 1% ophthalmic suspension eye drops, a topical corticosteroid for ocular inflammation, marketed in Egypt by Novartis.

• Most frequent: blurred vision, eye discharge and ocular discomfort (about 1-2% of patients).International label, same product · Health Products Regulatory Authority (HPRA)

• Hypersensitivity; epithelial herpes simplex keratitis, vaccinia, varicella and most viral corneal/conjunctival diseases; mycobacterial or fungal eye infections; acute purulent untreated infections; undiagnosed red eye; amoebic infections.International label, same product · Health Products Regulatory Authority (HPRA)

• Prolonged use may cause ocular hypertension/glaucoma, optic nerve damage, visual field defects and posterior subcapsular cataract; check intraocular pressure frequently. May mask or worsen infections and slow corneal healing; perforation possible in thin cornea/sclera. Contains benzalkonium chloride.International label, same product · Health Products Regulatory Authority (HPRA)

• Topical NSAIDsConcomitant use may increase corneal healing problems.Health Products Regulatory Authority (HPRA)

• Limited data in pregnancy; animal corticosteroid studies show reproductive toxicity; do not use in pregnancy unless clearly necessary.International label, same product · Health Products Regulatory Authority (HPRA)
• Unknown whether rimexolone is excreted in human milk; decide between stopping breastfeeding or therapy.International label, same product · Health Products Regulatory Authority (HPRA)

• Rimexolone: Corticosteroid that suppresses the inflammatory response to mechanical, chemical or immunological agents (oedema, fibrin deposition, capillary dilation, leucocyte migration) (Vexol SmPC).